Thursday, August 04, 2016 1:17:03 PM
http://www.puramatrix.com/clinical_applications_hemostasis.html
"The ability to stop and control bleeding is critically important to all surgical procedures and to the practice of medicine in general.
Based on the self-assembling peptide platform technology of PuraMatrix®, 3-D Matrix has obtained CE mark approval for the surgical hemostatic agent PuraStat®.
PuraStat® gels upon blood contact and stops bleeding (hemostasis) via mechanical blocking of the bleeding site for diffuse bleeds while allowing full, transparent view of the target area. PuraStat® has a number of unique features that distinguish it from existing products."
Recent ARTH News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 09:00:11 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM